Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 309.00
Bid: 308.50
Ask: 309.50
Change: 1.00 (0.32%)
Spread: 1.00 (0.324%)
Open: 315.50
High: 315.50
Low: 303.50
Prev. Close: 308.00
IHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

HMRC VAT Notice

20 Sep 2022 12:45

RNS Number : 0137A
IntegraFin Holdings plc
20 September 2022
 

IntegraFin Holdings plc

HMRC VAT Notice

For Immediate Release

20 September 2022

IntegraFin Holdings plc

HMRC VAT Notice

IntegraFin Holdings plc (''IHP'') issued a RNS on 21 June 2022 concerning HM Revenue & Custom's (HMRC) decision that Integrated Application Development Pty Ltd ("IAD")'s membership of a UK value added tax (''VAT'') group is terminated with effect from 4 July 2016. The consequence of the exclusion of IAD from the UK VAT group is that the services provided by IAD would be subject to VAT which needs to be accounted for under the reverse-charge mechanism. Integrated Financial Arrangements Ltd (the "Company"), a subsidiary of IHP, requested a second, independent, review of HMRC's decision.

Today the Company received notice from HMRC that it had completed this second review and is upholding its original decision.

Having taken legal advice, the Company now intends to appeal HMRC's decision to the First-tier Tribunal (Tax Chamber).

Prior to appealing the decision, the Company is required to pay HMRC the VAT that has been assessed as being due since 4 July 2016. The VAT due for the period 4 July 2016 to 30 September 2021 is £8.0m. The VAT due for the financial year ending 30 September 2022 is £1.8m. The payment to HMRC of VAT due will come from Group cash reserves. As at 31 March 2022, we disclosed total Group consolidated corporate cash on the IHP balance sheet of £177.8m, including an amount of £51.6m not allocated to regulatory requirements, risk appetites, taxation and dividend payments. Therefore, after the payment to HMRC, we will continue to hold extensive Group cash reserves.

Pending the outcome of the appeal there will be an ongoing VAT liability (accountable under the reverse-charge mechanism) which we estimate to be £2.4m for the financial year ending 30 September 2023. The VAT charge projection is based on the assumption that staff recruitment continues in the way that we previously announced.

If the Company's appeal is successful, all VAT payments detailed above will be repaid with interest.

IHP had previously disclosed in Note 36 to its financial statements for the year ended 30 September 2021 a contingent liability for the potential payments to HMRC.

In accordance with required accounting treatment, IHP will now include in its financial statements for the year ending 30 September 2022 a charge to its Statement of Comprehensive Income for the full amount of the VAT amount due since 4 July 2016 (£9.8m). Additionally, IHP will also make a provision in its financial statements for the year ending 30 September 2022 for the calculated interest payable to HMRC, which would need to be paid if the appeal is not successful. We estimate that this provision amount will be £0.8m for the period from 4 July 2016 to 30 September 2022.

We will make further announcements about any material developments as the appeal process progresses.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("EUWA")) ("UK MAR")

LEI Number: 213800CYIZKXK9PQYE87 

 

Enquiries

Luke Carrivick - IHP Head of Investor Relations +44 (0)20 7608 5463

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSLALIIFIF
Date   Source Headline
27th Jan 20211:51 pmRNSDirector/PDMR Shareholding
22nd Jan 20213:28 pmRNSDirector/PDMR Shareholding
20th Jan 20212:00 pmRNSNotice of AGM
19th Jan 20217:00 amRNS1st Quarter Results
15th Jan 20211:47 pmRNSDirector/PDMR Shareholding
13th Jan 20214:08 pmRNSHolding(s) in Company
11th Jan 20212:34 pmRNSHolding(s) in Company
11th Jan 202111:30 amRNSAcquisition
5th Jan 20216:28 pmRNSListing Rule 9.6.14(R) Disclosure
4th Jan 20214:45 pmRNSNo intention to make an offer for Nucleus
23rd Dec 20201:42 pmRNSDirector/PDMR Shareholding
17th Dec 202010:00 amRNSHolding(s) in Company
17th Dec 20207:00 amRNSFinal Results
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
25th Nov 20207:00 amRNSAppointment of Joint Corporate Broker
24th Nov 20204:48 pmRNSDirector/PDMR Shareholding
5th Nov 202011:37 amRNSHolding(s) in Company
23rd Oct 20203:29 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSQ4 Funds Under Direction Update
30th Sep 202011:04 amRNSResult of General Meeting
28th Sep 20204:21 pmRNSHolding(s) in Company
25th Sep 202010:52 amRNSHolding(s) in Company
23rd Sep 20204:54 pmRNSHolding(s) in Company
23rd Sep 20204:22 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
15th Sep 20203:35 pmRNSDirector/PDMR Shareholding
9th Sep 20207:00 amRNSNotice of GM
7th Sep 202012:30 pmRNSDirector/PDMR Shareholding
1st Sep 20201:00 pmRNSDirectorate Change
24th Aug 20203:13 pmRNSDirector/PDMR Shareholding
5th Aug 20204:54 pmRNSDirector/PDMR Shareholding
4th Aug 20201:43 pmRNSHolding(s) in Company
3rd Aug 20209:45 amRNSHolding(s) in Company
27th Jul 202011:40 amRNSDirector/PDMR Shareholding
24th Jul 20203:16 pmRNSHolding(s) in Company
22nd Jul 20202:01 pmRNSDirector/PDMR Shareholding
22nd Jul 202012:00 pmRNSHolding(s) in Company
21st Jul 20207:00 amRNSQ3 Funds Under Direction Update
14th Jul 20202:30 pmRNSHolding(s) in Company
29th Jun 20203:10 pmRNSDirector/PDMR Shareholding
25th Jun 202010:27 amRNSDirector/PDMR Shareholding
24th Jun 202010:21 amRNSDirector/PDMR Shareholding
1st Jun 20201:35 pmRNSDirector/PDMR Shareholding
22nd May 20204:11 pmRNSHolding(s) in Company
22nd May 20202:11 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSHalf-year Report
19th May 20209:38 amRNSHolding(s) in Company
22nd Apr 20204:13 pmRNSDirector/PDMR Shareholding
21st Apr 20207:00 amRNSQ2 Funds Under Direction Update
27th Mar 20205:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.